Adequate doses of autoantigen administered using the appropriate route may create tolerance and stop autoimmunity

Diabetologia

Volumn 52, Issue 1, 2009, Pages 175-176

  Ludvigsson, J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Administration; Autoantigens; Autoimmunity; GAD; Immunotherapy; Tolerance; Type 1 diabetes

Indexed keywords

ALUMINUM POTASSIUM SULFATE; AUTOANTIGEN; GLUTAMATE DECARBOXYLASE 65; HEAT SHOCK PROTEIN; IMMUNOLOGICAL ADJUVANT; INSULIN; PROTEIN DIAPEP277; UNCLASSIFIED DRUG;

ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CLINICAL TRIAL; DISEASE COURSE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERANCE; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIFESTYLE MODIFICATION; LYMPHOCYTE MIGRATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TREATMENT OUTCOME; VACCINATION;

AUTOANTIGENS; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY;

EID: 57249096985     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-008-1211-9     Document Type: Article

References (9)

1. B Keymeulen E Vandemeulebroucke AG Ziegler 2005 Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes N Engl J Med 352 2598 2608
2. KC Herold SE Gitelman U Masharani 2005 A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes Diabetes 54 1763 1769
3. WHO position paper (1998) Allergy and immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27-29 1997. Allergy 53(44 Suppl):1-42
4. Diabetes Prevention Trial-Type 1 Diabetes Study Group 2002 Effects of insulin in relatives of patients with type 1 diabetes mellitus N Engl J Med 346 1685 1691
5. JS Skyler JP Krischer J Wolfsdorf 2005 Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial-Type 1 Diabetes Care 28 1068 1076
6. Näntö-Salonen K, Kupila A, Simell S et al (2008) Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double blind randomised controlled trial. Lancet doi: 10.1016/S0140-6736(08)61309-4
7. I Raz D Elias A Avron M Tamir M Metzger IR Cohen 2001 Beta cell function in new-onset type 1 diabetes and immunomodulation with a heat shock protein peptide (DiaPep277): a randomised, double-blind, Phase II trial Lancet 358 1749 1753
8. NC Schloot G Meierhoff C Lengyel 2007 Effect of heat shock protein peptide DiaPep277 on beta-cell function in paediatric and adult patients with recent-onset diabetes mellitus type 1: two prospective, randomized, double-blind Phase II trials Diabetes Metab Res Rev 23 276 285
9. Ludvigsson J, Faresjö M, Hjort M et al (2008) GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med doi: 10.1056/NEJMoa0804328